I. Longini

Joshua M. Epstein, A. Nizam, D. Cummings, 2007, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

A mathematical model for predicting the geographic spread of new infectious agents

I. Longini, 1988 .

The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak

Jessica T Davis, A. Vespignani, C. Viboud, 2020, Science.

Statistical analysis of the stages of HIV infection using a Markov model.

J. Ward, H. Hethcote, I. Longini, 1989, Statistics in medicine.

The Global Transmission and Control of Influenza

M. Halloran, I. Longini, E. Kenah, 2011, PloS one.

Estimating household and community transmission parameters for influenza.

I M Longini, J P Fox, J S Koopman, 1982, American journal of epidemiology.

Direct and indirect effects in vaccine efficacy and effectiveness.

M E Halloran, I M Longini, C J Struchiner, 1991, American journal of epidemiology.

The stages of HIV infection: waiting times and infection transmission probabilities

Ira M. Longini, Michael Haber, Robert Horsburgh, 1989 .

Household Transmission of Vibrio cholerae in Bangladesh

M. Halloran, I. Longini, E. Kenah, 2014, PLoS neglected tropical diseases.

Vaccination strategies for epidemic cholera in Haiti with implications for the developing world

M. Halloran, I. Longini, D. Chao, 2011, Proceedings of the National Academy of Sciences.

El Tor cholera with severe disease: a new threat to Asia and beyond

A. Nizam, I. Longini, R. Colwell, 2009, Epidemiology and Infection.

Increased Isolation Frequency of Toxigenic Vibrio cholerae O1 from Environmental Monitoring Sites in Haiti

I. Longini, Afsar Ali, M. T. Alam, 2015, PloS one.

Critical Factors Influencing the Occurrence of Vibrio cholerae in the Environment of Bangladesh

Rita R. Colwell, J. Glenn Morris, David A. Sack, 2005, Applied and Environmental Microbiology.

Epidemic and endemic cholera trends over a 33-year period in Bangladesh.

Ira M Longini, Mohammed Yunus, A. Nizam, 2002, The Journal of infectious diseases.

A simulation model of AIDS in San Francisco: I. Model formulation and parameter estimation.

I M Longini, H. Hethcote, I. Longini, 1991, Mathematical biosciences.

Towards a quantitative understanding of the within-host dynamics of influenza A infections

Andreas Handel, Rustom Antia, Ira M. Longini, 2010, Journal of The Royal Society Interface.

Controlling Dengue with Vaccines in Thailand

S. Halstead, M. Halloran, I. Longini, 2012, PLoS neglected tropical diseases.

Spatiotemporal spread of the 2014 outbreak of Ebola virus disease in Liberia and the effectiveness of non-pharmaceutical interventions: a computational modelling analysis.

Alessandro Vespignani, S. Merler, M. Halloran, 2015, Lancet. Infectious Diseases (Print).

The effect of travel restrictions on the spread of the 2019 novel coronavirus (2019-nCoV) outbreak

Jessica T Davis, A. Vespignani, C. Viboud, 2020, medRxiv.

Spread of Zika virus in the Americas

Alessandro Vespignani, S. Merler, M. Halloran, 2017, Proceedings of the National Academy of Sciences.

Household and community transmission parameters from final distributions of infections in households.

I. Longini, J. Koopman, 1982, Biometrics.

The critical vaccination fraction for heterogeneous epidemic models.

I. Longini, A. Hill, 2003, Mathematical biosciences.

Modeling the impact of social distancing, testing, contact tracing and household quarantine on second-wave scenarios of the COVID-19 epidemic

A. Vespignani, A. Pentland, S. Merler, 2020, medRxiv.

Inferring high-resolution human mixing patterns for disease modeling

Seattle, Chengdu, Gainesville, 2020, Nature communications.

Household Secondary Attack Rate of COVID-19 and Associated Determinants

L. Fang, N. Dean, L. Luo, 2020, medRxiv.

Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study

L. Fang, N. Dean, L. Luo, 2020, The Lancet Infectious Diseases.

Estimating the establishment of local transmission and the cryptic phase of the COVID-19 pandemic in the USA

A. Vespignani, C. Viboud, S. Merler, 2020, medRxiv.

Estimating the effect of cooperative versus uncooperative strategies of COVID-19 vaccine allocation: a modeling study

Jessica T Davis, A. Vespignani, M. Halloran, 2020 .

The Effects of Vector Movement and Distribution in a Mathematical Model of Dengue Transmission

M. Halloran, I. Longini, D. Chao, 2013, PloS one.

Achieving coordinated national immunity and cholera elimination in Haiti through vaccination: a modelling study

Elizabeth C. Lee, A. Rinaldo, M. Halloran, 2020, The Lancet. Global health.

Role of the primary infection in epidemics of HIV infection in gay cohorts.

I. Longini, J. Koopman, J. Jacquez, 1995, Journal of acquired immune deficiency syndromes.

Probability of female-to-male transmission of HIV-1 in Thailand

G. Satten, I. Longini, T. Mastro, 1994, The Lancet.

Modelling the female-to-male per-act HIV transmission probability in an emerging epidemic in Asia.

G. Satten, I. Longini, T. Mastro, 1994, Statistics in medicine.

Optimizing Vaccine Allocation at Different Points in Time during an Epidemic

Ira M. Longini, Laura Matrajt, I. Longini, 2010, PloS one.

Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial

John-Arne Røttingen, Sema Mandal, Matthias Egger, 2015, The Lancet.

Interpretation and estimation of vaccine efficacy under heterogeneity.

M E Halloran, I M Longini, M. Halloran, 1992, American journal of epidemiology.

A Frailty Mixture Model for Estimating Vaccine Efficacy

M. Elizabeth Halloran, Ira M. Longini, M. Halloran, 1996 .

Optimal vaccine trial design when estimating vaccine efficacy for susceptibility and infectiousness from multiple populations.

M E Halloran, I M Longini, M. Halloran, 1998, Statistics in medicine.

The dengue vaccine pipeline: Implications for the future of dengue control.

M. Halloran, I. Longini, A. Durbin, 2015, Vaccine.

Simulation studies of influenza epidemics: assessment of parameter estimation and sensitivity.

I M Longini, E Ackerman, S K Seaholm, 1984, International journal of epidemiology.

Assessing the International Spreading Risk Associated with the 2014 West African Ebola Outbreak

Alessandro Vespignani, Dennis Chao, M. Elizabeth Halloran, 2014, PLoS currents.

Ring vaccination with rVSV-ZEBOV under expanded access in response to an outbreak of Ebola virus disease in Guinea, 2016: an operational and vaccine safety report

Mosoka P. Fallah, Pierre-Stéphane Gsell, Ana Maria Henao-Restrepo, 2017, The Lancet. Infectious diseases.

Population-wide benefits of routine vaccination of children against influenza.

M Elizabeth Halloran, Ira M Longini, A. Nizam, 2005, Vaccine.

A Theoretic Framework to Consider the Effect of Immunizing Schoolchildren Against Influenza: Implications for Research

I. Longini, 2012, Pediatrics.

Community Studies for Vaccinating Schoolchildren Against Influenza

M. Elizabeth Halloran, Ira M. Longini, M. Halloran, 2006, Science.

Strategy for distribution of influenza vaccine to high-risk groups and children.

M Elizabeth Halloran, Ira M Longini, M. Halloran, 2005, American journal of epidemiology.

Statistical inference for infectious diseases. Risk-specific household and community transmission parameters.

I M Longini, J S Koopman, I. Longini, 1988, American journal of epidemiology.

Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial: implications for influenza epidemic control.

M E Halloran, I M Longini, A. Nizam, 2000, Vaccine.

Markov Chains with Measurement Error: Estimating the ‘True’ Course of a Marker of the Progression of Human Immunodeficiency Virus Disease

Glen A. Satten, Ira M. Longini, G. Satten, 1996 .

DURATION OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION BEFORE DETECTION OF ANTIBODY

J. Ward, I. Longini, S. Holmberg, 1989, The Lancet.

Analytic Insights Into the Population Level Impact of Imperfect Prophylactic HIV Vaccines

S. Self, L. Abu-Raddad, I. Longini, 2007, Journal of acquired immune deficiency syndromes.

Predicting the global spread of new infectious agents.

I M Longini, S B Thacker, P E Fine, 1986, American journal of epidemiology.

Containing Pandemic Influenza at the Source

M. Elizabeth Halloran, Ira M. Longini, Derek A. T. Cummings, 2005, Science.

The ecological effects of individual exposures and nonlinear disease dynamics in populations.

I M Longini, J S Koopman, I. Longini, 1994, American journal of public health.

Public health. Community studies for vaccinating schoolchildren against influenza.

M. Halloran, I. Longini, 2006, Science.

Lecture Notes on Stochastic Processes in Biostatistics: Applications to Infectious Diseases

I. Longini, 2003 .

What is the best control strategy for multiple infectious disease outbreaks?

I. Longini, A. Handel, R. Antia, 2007, Proceedings of the Royal Society B: Biological Sciences.

Intervention strategies for an influenza pandemic taking into account secondary bacterial infections.

Andreas Handel, Rustom Antia, Ira M Longini, 2009, Epidemics.

Antiviral resistance and the control of pandemic influenza: the roles of stochasticity, evolution and model details.

Andreas Handel, Rustom Antia, Ira M Longini, 2009, Journal of theoretical biology.

Projected spread of Zika virus in the Americas

Alessandro Vespignani, S. Merler, M. Halloran, 2016, bioRxiv.

Design of vaccine efficacy trials during public health emergencies

R. Brookmeyer, M. Halloran, N. Dean, 2019, Science Translational Medicine.

DESIGN OF VACCINE TRIALS DURING OUTBREAKS WITH AND WITHOUT A DELAYED VACCINATION COMPARATOR.

M Elizabeth Halloran, Ira M Longini, Natalie E Dean, 2018, The annals of applied statistics.

Live-attenuated tetravalent dengue vaccines: The needs and challenges of post-licensure evaluation of vaccine safety and effectiveness.

I. Longini, Peter G. Smith, A. Lopez, 2017, Vaccine.

Real-Time Assessment of the International Spreading Risk Associated with the 2014 West African Ebola Outbreak

Alessandro Vespignani, M. Halloran, V. Colizza, 2016 .

Environmental and genetic sources of familial aggregation of blood pressure in Tecumseh, Michigan.

I. Longini, M. Higgins, J. Keller, 1984, American journal of epidemiology.

Assessing Indirect, Total, and Overall Effects

M. Halloran, I. Longini, C. Struchiner, 2010 .

Comparative modelling of dengue vaccine public health impact ( CMDVI ) 17 / 03 / 2016 Authors

Thomas J. Hladish, Carl A. B. Pearson, D. Cummings, 2016 .

The TIRS trial: protocol for a cluster randomized controlled trial assessing the efficacy of preventive targeted indoor residual spraying to reduce Aedes-borne viral illnesses in Merida, Mexico

Thomas J. Hladish, M. Halloran, L. Waller, 2020, Trials.

Modeling the potential impact of a partially effective HIV vaccine in a generalized African HIV-1 epidemic : Evaluating strategies for HIV vaccine use

I. Longini, J. Esparza, M. Ackers, 2003 .

Exposure efficacy and change in contact rates in evaluating prophylactic HIV vaccines in the field.

M. Halloran, I. Longini, M. Haber, 1994, Statistics in medicine.

Factors Associated With Household Transmission of SARS-CoV-2

M. Halloran, N. Dean, I. Longini, 2021, JAMA network open.

Ensemble forecast modeling for the design of COVID-19 vaccine efficacy trials

A. Vespignani, D. Cummings, M. Halloran, 2020, Vaccine.

Estimation of vaccine efficacy from epidemics of acute infectious agents under vaccine-related heterogeneity.

M. Halloran, I. Longini, M. Haber, 1993, Mathematical biosciences.

Title Quantifying the Epidemiological Impact of Vector Control on Dengue Permalink

David L. Smith, S. Ritchie, I. Kleinschmidt, 2016 .

Efficacy of virucidal nasal tissues in interrupting familial transmission of respiratory agents. A field trial in Tecumseh, Michigan.

I. Longini, A. Monto, 1988, American journal of epidemiology.

Transmissibility and Pathogenicity of Ebola Virus: A Systematic Review and Meta-analysis of Household Secondary Attack Rate and Asymptomatic Infection.

M. Halloran, N. Dean, I. Longini, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Household secondary attack rates of SARS-CoV-2 by variant and vaccination status: an updated systematic review and meta-analysis

M. Halloran, N. Dean, I. Longini, 2022, medRxiv.

Simulation of mechanisms of viral interference in influenza.

I. Longini, E. Ackerman, S. Seaholm, 1990, International journal of epidemiology.

The public health value of vaccines beyond efficacy: methods, measures and outcomes

T. Bärnighausen, W. Edmunds, I. Longini, 2017, BMC Medicine.

Quantifying the importance and location of SARS-CoV-2 transmission events in large metropolitan areas

A. Vespignani, A. Pentland, E. Moro, 2020, medRxiv.

Online Supporting Text S 2 : Parameter selection for the model

S. Halstead, M. Halloran, I. Longini, 2012 .

Estimating the risk of sustained community transmission of COVID-19 outside Mainland China

Jessica T Davis, A. Vespignani, C. Viboud, 2020 .

Quantifying the risk of local Zika virus transmission in the continental US during the 2015-2016 ZIKV epidemic

A. Vespignani, S. Merler, M. Halloran, 2018, bioRxiv.

Algorithms linking phylogenetic and transmission trees for molecular infectious disease epidemiology

M. Halloran, I. Longini, T. Britton, 2015 .

The global spread of drug-resistant influenza

Rustom Antia, Ira M Longini, Jesse D Bloom, 2012, Journal of The Royal Society Interface.

Neuraminidase Inhibitor Resistance in Influenza: Assessing the Danger of Its Generation and Spread

Andreas Handel, Rustom Antia, Ira M. Longini, 2007, PLoS Comput. Biol..

PREDICTIVE MODELING OF CHOLERA OUTBREAKS IN BANGLADESH.

J. Wakefield, M. Halloran, Ira M. Longini Jr, 2014, The annals of applied statistics.

Genetic and environmental sources of familial aggregation of body mass in Tecumseh, Michigan.

I. Longini, M. Higgins, J. Keller, 1984, Human biology.

COVID-19 vaccine trials should seek worthwhile efficacy

R. Peto, T. Fleming, I. Longini, 2020, The Lancet.

Temporal Confounding in the Test Negative Design.

M. Halloran, N. Dean, I. Longini, 2020, American journal of epidemiology.

Epidemiology Temporal Confounding in the Test-Negative Design

M. Halloran, N. Dean, I. Longini, 2020 .

The effect of disease prior to an outbreak on estimates of vaccine efficacy following the outbreak.

M. Halloran, I. Longini, M. Haber, 1995, American journal of epidemiology.

Safety of cold-adapted live influenza vaccine.

M. Halloran, I. Longini, W. P. Glezen, 2004, The Pediatric infectious disease journal.

Achieving coordinated national immunity and cholera elimination in Haiti through vaccination: a modelling study

Elizabeth C. Lee, A. Rinaldo, M. Halloran, 2019, The Lancet. Global health.

A platform trial design for preventive vaccines against Marburg virus and other emerging infectious disease threats

M. Halloran, T. Fleming, C. Donnelly, 2022, Clinical trials.

Cryptic transmission of SARS-CoV-2 and the first COVID-19 wave

Jessica T Davis, A. Vespignani, C. Viboud, 2021, Nature.

AIDS: modeling epidemic control

M. Halloran, I. Longini, 1995, Science.

Evolutionary consequences of delaying intervention for monkeypox

Carl T. Bergstrom, M. Halloran, I. Longini, 2022, The Lancet.

Cholera Transmission in Ouest Department of Haiti: Dynamic Modeling and the Future of the Epidemic

I. Longini, Yang Yang, A. Kirpich, 2015, PLoS neglected tropical diseases.

Designing effective control of dengue with combined interventions

Thomas J. Hladish, M. Halloran, I. Longini, 2020, Proceedings of the National Academy of Sciences.

Placebo-Controlled Trials of Covid-19 Vaccines - Why We Still Need Them.

V. Beral, R. Peto, T. Fleming, 2020, The New England journal of medicine.

Surrogates of Protection

M. Halloran, I. Longini, C. Struchiner, 2010 .

Considerations in boosting COVID-19 vaccine immune responses

Michael J. Ryan, J. Sterne, R. Peto, 2021, The Lancet.

Seroprevalence of Dengue Antibodies in Three Urban Settings in Yucatan, Mexico

M. Halloran, H. Gómez-Dantés, I. Longini, 2018, The American journal of tropical medicine and hygiene.

The Tecumseh study. XII. Enteric agents in the community, 1976-1981.

I. Longini, A. Monto, J. Koopman, 1983, The Journal of infectious diseases.

Household Secondary Attack Rates of SARS-CoV-2 by Variant and Vaccination Status

M. Halloran, N. Dean, I. Longini, 2022, JAMA network open.

Studies needed to address public health challenges of the 2009 H1N1 influenza pandemic: insights from modeling

J. Desenclos, C. Fraser, J. Wallinga, 2009, PLoS currents.

Preliminary results of models to predict areas in the Americas with increased likelihood of Zika virus transmission in 2017

A. Vespignani, D. Cummings, S. Merler, 2017, bioRxiv.

SARS-CoV-2 Variants and Vaccines

Michael J. Ryan, V. Beral, R. Peto, 2021, The New England journal of medicine.

Efficacy Estimates for Various COVID-19 Vaccines: What we Know from the Literature and Reports

M. Halloran, N. Dean, I. Longini, 2021, medRxiv.

Updated projections for COVID-19 omicron wave in Florida

Thomas J. Hladish, I. Longini, T. Hladish, 2022, medRxiv.

The Cholera Crisis in Africa

R. Glass, G. Dougan, I. Longini, 2009, Science.

Quantitative assessment of the role of male circumcision in HIV epidemiology at the population level.

Brianna R. Cash, L. Abu-Raddad, I. Longini, 2009, Epidemics.

Models for the statistical analysis of infectious disease data.

I M Longini, I. Longini, M. Haber, 1988, Biometrics.

Models of epidemics and endemicity in genetically variable host populations

I. Longini, 1983, Journal of mathematical biology.

Design and Analysis of Vaccine Studies

Claudio J. Struchiner, M. Elizabeth Halloran, Ira M. Longini, 2009 .

Estimating the stage-specific numbers of HIV infection using a Markov model and back-calculation.

I. Longini, N. Hessol, R. Byers, 1992, Statistics in medicine.

Finding optimal vaccination strategies for pandemic influenza using genetic algorithms.

M. Halloran, I. Longini, Rajan K. Patel, 2005, Journal of theoretical biology.

Cryptic transmission of SARS-CoV-2 and the first COVID-19 wave in Europe and the United States

A. Vespignani, C. Viboud, S. Merler, 2021, medRxiv.

Estimating the impact of COVID-19 vaccines allocation inequalities: a modeling study

A. Vespignani, M. Halloran, N. Perra, 2022 .

Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China

Wei Liu, M. Elizabeth Halloran, Ira M. Longini, 2020, medRxiv.

Household transmission of SARS-CoV-2 and risk factors for susceptibility and infectivity in Wuhan: a retrospective observational study

L. Fang, M. Halloran, N. Dean, 2021, The Lancet Infectious Diseases.

Household Transmission of SARS-CoV-2

M. Halloran, N. Dean, I. Longini, 2020, JAMA network open.

Assessing the impact of travel restrictions on international spread of the 2014 West African Ebola epidemic.

A Vespignani, M E Halloran, I M Longini, 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

A 4-year study of the epidemiology of Vibrio cholerae in four rural areas of Bangladesh.

Ira M Longini, Anwar Huq, Rita R Colwell, 2003, The Journal of infectious diseases.

Population Level Impact of an Imperfect Prophylactic Vaccine for Herpes Simplex Virus-2

L. Abu-Raddad, J. Schiffer, I. Longini, 2010, Sexually transmitted diseases.

Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics

M Elizabeth Halloran, Christopher Dye, Ira M Longini, 2009, Proceedings of the National Academy of Sciences.

Ebola and beyond

Eli N. Perencevich, Marc Lipsitch, Miguel A. Hernán, 2015, Science.

The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison Study

Mario Recker, Katia Koelle, Derek A T Cummings, 2016, PLoS medicine.

The Tecumseh Community Health Study.

I. Longini, M. Higgins, 1984, Progress in clinical and biological research.

Projected Impact of Dengue Vaccination in Yucatán, Mexico

M Elizabeth Halloran, Thomas J. Hladish, Ira M Longini, 2016, PLoS neglected tropical diseases.

Controlling Endemic Cholera with Oral Vaccines

Mohammad Yunus, Neeta Shenvi, Ira M Longini, 2007, PLoS medicine.

Household transmission of SARS-CoV-2: a systematic review and meta-analysis of secondary attack rate

M. Halloran, N. Dean, I. Longini, 2020, medRxiv.

Comparative Effectiveness of Different Strategies of Oral Cholera Vaccination in Bangladesh: A Modeling Study

M. Halloran, C. Troeger, I. Longini, 2014, PLoS neglected tropical diseases.

Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)

John-Arne Røttingen, Sema Mandal, Matthias Egger, 2017, The Lancet.

Genital Herpes Has Played a More Important Role than Any Other Sexually Transmitted Infection in Driving HIV Prevalence in Africa

S. Self, L. Abu-Raddad, I. Longini, 2008, PloS one.

The dynamics of CD4+ T-lymphocyte decline in HIV-infected individuals: a Markov modeling approach.

I M Longini, I. Longini, L. Gardner, 1991, Journal of acquired immune deficiency syndromes.

Spatio-temporal coherence of dengue, chikungunya and Zika outbreaks in Merida, Mexico

M Elizabeth Halloran, Thomas J. Hladish, Gonzalo M Vazquez-Prokopec, 2018, PLoS neglected tropical diseases.

Epidemiology of dengue and other arboviruses in a cohort of school children and their families in Yucatan, Mexico: Baseline and first year follow-up

M. Halloran, H. Gómez-Dantés, I. Longini, 2018, PLoS neglected tropical diseases.

Forecasting the effectiveness of indoor residual spraying for reducing dengue burden

M Elizabeth Halloran, Thomas J. Hladish, Gonzalo M Vazquez-Prokopec, 2018, PLoS neglected tropical diseases.

Quantifying the Epidemiological Impact of Vector Control on Dengue

David L. Smith, S. Ritchie, I. Kleinschmidt, 2016, PLoS neglected tropical diseases.

Transmission dynamics of Ebola virus disease and intervention effectiveness in Sierra Leone

Abdul Kamara, M Elizabeth Halloran, Wu-Chun Cao, 2016, Proceedings of the National Academy of Sciences.

Quantifying the risk of local Zika virus transmission in the contiguous US during the 2015–2016 ZIKV epidemic

Alessandro Vespignani, S. Merler, M. Halloran, 2018, BMC Medicine.

An introduction to the Marburg virus vaccine consortium, MARVAC

J. Dye, I. Longini, S. Günther, 2022, PLoS pathogens.

Hand, Foot, and Mouth Disease in China: Patterns of Spread and Transmissibility

J. Wakefield, Weizhong Yang, S. Self, 2011, Epidemiology.

Questionable efficacy of the rVSV-ZEBOV Ebola vaccine – Authors' reply

W. Edmunds, I. Longini, M. Kieny, 2018, The Lancet.

Changes in the primary outcome in Ebola vaccine trial – Authors' reply

M. Egger, W. Edmunds, I. Longini, 2016, The Lancet.

The Effect of Age on Transmission of 2009 Pandemic Influenza A (H1N1) in a Camp and Associated Households

M. Halloran, I. Longini, Yang Yang, 2011, Epidemiology.

No HIV stage is dominant in driving the HIV epidemic in sub-Saharan Africa

Ira M Longini, L. Abu-Raddad, I. Longini, 2008, AIDS.

Genomic epidemiology supports multiple introductions and cryptic transmission of Zika virus in Colombia

M. Halloran, I. Longini, T. Bedford, 2018, bioRxiv.

Assessing the Potential of a Candidate Dengue Vaccine with Mathematical Modeling

Mario Recker, Jan Medlock, Pejman Rohani, 2012, PLoS neglected tropical diseases.

The ring vaccination trial: a novel cluster randomised controlled trial design to evaluate vaccine efficacy and effectiveness during outbreaks, with special reference to Ebola

John-Arne Røttingen, Ira M. Longini, Sema Mandal, 2015, BMJ : British Medical Journal.

Emerging, evolving, and established infectious diseases and interventions

M. Halloran, I. Longini, 2014, Science.

Estimation of incidence of HIV infection using cross-sectional marker surveys.

I. Longini, G. A. Statten, 1994, Biometrics.

Subtype-specific transmission probabilities for human immunodeficiency virus type 1 among injecting drug users in Bangkok, Thailand.

M. Hudgens, G. Satten, M. Halloran, 2002, American journal of epidemiology.

Have the explosive HIV epidemics in sub-Saharan Africa been driven by higher community viral load?

J. Kublin, L. Abu-Raddad, I. Longini, 2013, AIDS.

he dengue vaccine pipeline : Implications for the future f dengue control

I. Longini, auren M. Schwartza, M. E. Halloranb, 2015 .

Simulations for designing and interpreting intervention trials in infectious diseases

Alessandro Vespignani, Jukka-Pekka Onnela, Marc Lipsitch, 2017, bioRxiv.

Transmissibility of Norovirus in Urban Versus Rural Households in a Large Community Outbreak in China

M. Halloran, I. Longini, Yang Yang, 2018, Epidemiology.

Modeling cholera outbreaks.

Ira M Longini, I. Longini, D. Chao, 2014, Current topics in microbiology and immunology.

Preclinical Assessment of HIV Vaccines and Microbicides by Repeated Low-Dose Virus Challenges

I. Longini, S. Staprans, M. Feinberg, 2005, PLoS medicine.

Study designs for evaluating different efficacy and effectiveness aspects of vaccines.

M E Halloran, I M Longini, C J Struchiner, 1997, American journal of epidemiology.

The Tecumseh Study. XVI: Family and community sources of rotavirus infection.

I M Longini, J S Koopman, I. Longini, 1989, American journal of epidemiology.

Use of immunological markers and continuous‐time Markov models to estimate progression of HIV infection in homosexual men

I M Longini, G A Satten, R A Coutinho, 1996, AIDS.

Effect of routine use of therapy in slowing the clinical course of human immunodeficiency virus (HIV) infection in a population-based cohort.

I M Longini, I. Longini, J. Karon, 1993, American journal of epidemiology.

Modeling Markers of Disease Progression by a Hidden Markov Process: Application to Characterizing CD4 Cell Decline

S Richardson, I M Longini, C Guihenneuc-Jouyaux, 2000, Biometrics.

The Statistics of HIV.

I. Longini, 1994, Science.

The contribution of neighbours to an individual's risk of typhoid outcome

M. Halloran, I. Longini, D. Chao, 2015, Epidemiology and Infection.

Dengue seroprevalence in a cohort of schoolchildren and their siblings in Yucatan, Mexico (2015-2016)

M. Halloran, H. Gómez-Dantés, I. Longini, 2018, PLoS neglected tropical diseases.

Efficacy of trivalent, cold-adapted, influenza virus vaccine against influenza A (Fujian), a drift variant, during 2003-2004.

M. Halloran, I. Longini, P. Piedra, 2007, Vaccine.

Estimation of Vaccine Efficacy in Non‐Randomly Mixing Populations

M. Halloran, I. Longini, M. Haber, 1995 .

COVID-19 vaccine trials: The use of active controls and non-inferiority studies

T. Fleming, I. Longini, P. Krause, 2021, Clinical trials.

Effects of infection history on dengue virus infection and pathogenicity

M. Halloran, I. Longini, Yang Yang, 2019, Nature Communications.

Efficiency of Estimating Vaccine Efficacy for Susceptibility and Infectiousness: Randomization by Individual Versus Household

M E Halloran, I M Longini, M. Halloran, 1999, Biometrics.

Containing Ebola at the Source with Ring Vaccination

Alessandro Vespignani, Stefano Merler, Marco Ajelli, 2016, PLoS neglected tropical diseases.

Tecumseh study of illness. XIII. Influenza infection and disease, 1976-1981.

I. Longini, A. Monto, J. Koopman, 1985, American journal of epidemiology.

Using validation sets for outcomes and exposure to infection in vaccine field studies.

M E Halloran, I M Longini, M. Halloran, 2001, American journal of epidemiology.

Creating a Framework for Conducting Randomized Clinical Trials during Disease Outbreaks.

Philip R Krause, Thomas Jaki, M Elizabeth Halloran, 2020, The New England journal of medicine.

Measures of the effects of vaccination in a randomly mixing population.

M. Halloran, I. Longini, M. Haber, 1991, International journal of epidemiology.

The ring vaccination trial design for the estimation of vaccine efficacy and effectiveness during infectious disease outbreaks

N. Dean, I. Longini, 2022, Clinical trials.

Using simulated infectious disease outbreaks to inform site selection and sample size for individually randomized vaccine trials during an ongoing epidemic

A. Vespignani, M. Halloran, A. Pastore y Piontti, 2021, Clinical trials.

Using simulated infectious disease outbreaks to guide the design of individually randomized vaccine trials

A. Vespignani, M. Halloran, N. Dean, 2021, medRxiv.

Considerations for the design of vaccine efficacy trials during public health emergencies

Christl A. Donnelly, Martha Nason, M. Elizabeth Halloran, 2018, bioRxiv.

Nonparametric Maximum Likelihood Estimation for Competing Risks Survival Data Subject to Interval Censoring and Truncation

I M Longini, G A Satten, M. Hudgens, 2001, Biometrics.

Estimating benefits of screening from observational cohort studies.

I. Longini, W. Flanders, W. Dana Flanders, 1990, Statistics in medicine.

Determinants of Transmission Risk During the Late Stage of the West African Ebola Epidemic

R. Eggo, W. Edmunds, A. Kucharski, 2019, American journal of epidemiology.

Designing a Study of Correlates of Risk for Ebola Vaccination

M. Halloran, I. Longini, P. Gilbert, 2018, bioRxiv.

Design of Vaccine Trials during Outbreaks with and without a Delayed Vaccination Comparator

M. Halloran, N. Dean, I. Longini, 2016, bioRxiv.

Spatiotemporal dynamics of the Ebola epidemic in Guinea and implications for vaccination and disease elimination: a computational modeling analysis

Alessandro Vespignani, Stefano Merler, Marco Ajelli, 2016, BMC Medicine.

Ebola vaccination – Authors' reply

M. Egger, N. Dean, W. Edmunds, 2015, The Lancet.

Biofilms Comprise a Component of the Annual Cycle of Vibrio cholerae in the Bay of Bengal Estuary

A. Nizam, I. Longini, R. Colwell, 2018, mBio.

Studies Needed to Address Public Health Challenges of the 2009 H1N1 Influenza Pandemic: Insights from Modeling

Marc Lipsitch, Christophe Fraser, Ira M. Longini, 2010, PLoS medicine.

Molecular Infectious Disease Epidemiology: Survival Analysis and Algorithms Linking Phylogenies to Transmission Trees

Tom Britton, Eben Kenah, M. Elizabeth Halloran, 2015, PLoS Comput. Biol..

Dependency of Vaccine Efficacy on Preexposure and Age: A Closer Look at a Tetravalent Dengue Vaccine

M. Halloran, I. Longini, Yang Yang, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Effects of infection history on dengue virus infection and pathogenicity

M. Halloran, I. Longini, J. Sugimoto, 2019, Nature Communications.

Comparative modelling of dengue vaccine public health impact: Report to the World Health Organisation

D. Cummings, M. Jit, R. Reiner, 2016 .

Reply to Aguiar and Stollenwerk.

M. Halloran, I. Longini, Yang Yang, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Optimal Vaccine Allocation for the Early Mitigation of Pandemic Influenza

M. Elizabeth Halloran, Ira M. Longini, Laura Matrajt, 2013, PLoS Comput. Biol..

Antiviral drugs: distinguish treatment from prophylaxis

B. Cowling, I. Longini, S. Ng, 2009, BMJ : British Medical Journal.

Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study

A. Vespignani, C. Viboud, S. Merler, 2020, medRxiv.

Estimation of vaccine efficacy in the presence of waning: application to cholera vaccines.

M. Halloran, I. Longini, J. Clemens, 1998, American journal of epidemiology.

eAppendix Hand , Foot and Mouth Disease in China : Patterns of Spread and Transmissibility during 2008-2009

J. Wakefield, Weizhong Yang, S. Self, 2011 .

School-Located Influenza Vaccination Reduces Community Risk for Influenza and Influenza-Like Illness Emergency Care Visits

Gloria P. Lipori, M. Halloran, I. Longini, 2014, PloS one.

Planning for the control of pandemic influenza A (H1N1) in Los Angeles County and the United States.

M Elizabeth Halloran, Nicole E Basta, Ira M Longini, 2011, American journal of epidemiology.

Estimability and interpretation of vaccine efficacy using frailty mixing models.

M E Halloran, I M Longini, C J Struchiner, 1996, American journal of epidemiology.

Determinants and predictors of dengue infection in Mexico.

I M Longini, J S Koopman, I. Longini, 1991, American journal of epidemiology.

Online Supporting Text S 1 : Dengue transmission model description

S. Halstead, M. Halloran, I. Longini, 2012 .

Augmented HIV vaccine trial design for estimating reduction in infectiousness and protective efficacy.

M E Halloran, I M Longini, M. Halloran, 1998, Statistics in medicine.

Measuring vaccine efficacy for both susceptibility to infection and reduction in infectiousness for prophylactic HIV-1 vaccines.

M E Halloran, I M Longini, M. Halloran, 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Estimating the impact of COVID-19 vaccine inequities: a modeling study

A. Vespignani, M. Halloran, N. Perra, 2023, Nature communications.

A Bayesian Framework for Estimating Vaccine Efficacy per Infectious Contact.

M. Halloran, I. Longini, Yang Yang, 2009, The annals of applied statistics.

Direct and total effectiveness of the intranasal, live-attenuated, trivalent cold-adapted influenza virus vaccine against the 2000-2001 influenza A(H1N1) and B epidemic in healthy children.

M. Halloran, I. Longini, P. Piedra, 2004, Archives of pediatrics & adolescent medicine.

Effectiveness of SARS-CoV-2 vaccines against Omicron infection and severe events: a systematic review and meta-analysis of test-negative design studies

I. Longini, Yang Yang, Mingjin Liu, 2023, Frontiers in Public Health.

Estimates of the US health impact of influenza.

I. Longini, A. Monto, K. Sullivan, 1993, American journal of public health.

Intermediate levels of vaccination coverage may minimize seasonal influenza outbreaks

M. Halloran, I. Longini, A. Handel, 2018, PloS one.

One versus two doses: What is the best use of vaccine in an influenza pandemic?

M. Halloran, I. Longini, T. Britton, 2015, Epidemics.

Rapid review and meta-analysis of serial intervals for SARS-CoV-2 Delta and Omicron variants

A. Vespignani, M. Halloran, N. Dean, 2023, BMC Infectious Diseases.

Inferring high-resolution human mixing patterns for disease modeling

A. Vespignani, S. Merler, M. Halloran, 2020, Nature Communications.

Estimating efficacy of trivalent, cold-adapted, influenza virus vaccine (CAIV-T) against influenza A (H1N1) and B using surveillance cultures.

H. Chu, M. Halloran, I. Longini, 2003, American journal of epidemiology.

Have the explosive HIV epidemics in sub-Saharan Africa been driven by higher community viral load?

J. Kublin, L. Abu-Raddad, I. Longini, 2013, AIDS.

Extrapolating theoretical efficacy of inactivated influenza A/H5N1 virus vaccine from human immunogenicity studies.

Laura Matrajt, I. Longini, L. Matrajt, 2016, Vaccine.

Overview of Vaccine Effects and Study Designs

M. Halloran, I. Longini, C. Struchiner, 2010 .

A chain binomial model of endemicity

I. Longini, 1980 .

Model‐based estimation of vaccine effects from community vaccine trials

A. Nizam, M. Halloran, I. Longini, 2002, Statistics in medicine.

Preliminary assessment of the International Spreading Risk Associated with the 2019 novel Coronavirus (2019-nCoV) outbreak in Wuhan City

A. Vespignani, Matteo Chinazzi, I. Longini, 2020 .

Statistical procedures for estimating the community probability of illness in family studies: rhinovirus and influenza.

I M Longini, J S Koopman, I. Longini, 1984, International journal of epidemiology.

Understanding HIV epidemics: aggregate viral load metrics and 'smoking guns'.

J. Kublin, L. Abu-Raddad, I. Longini, 2013, AIDS.

A discrete-time model for the statistical analysis of infectious disease incidence data.

I M Longini, I. Longini, A. Monto, 1992, Biometrics.

Design and evaluation of prophylactic interventions using infectious disease incidence data from close contact groups

M Elizabeth Halloran, Yang Yang, Ira M Longini, 2006, Journal of the Royal Statistical Society. Series C, Applied statistics.

Detecting Human-to-Human Transmission of Avian Influenza A (H5N1)

Yang Yang, M. Elizabeth Halloran, Ira M. Longini, 2007, Emerging infectious diseases.

Assessing risk factors for transmission of infection.

I M Longini, J A Jacquez, J S Koopman, 1991, American journal of epidemiology.

Controlling cholera in the Ouest Department of Haiti using oral vaccines

I. Longini, Yang Yang, A. Kirpich, 2017, PLoS neglected tropical diseases.

Counting Process Models for Infectious Disease Data: Distinguishing Exposure to Infection from Susceptibility

M. Elizabeth Halloran, Ira M. Longini, M. Halloran, 1996 .

The effect of travel restrictions on the spread of the 2019 novel coronavirus (2019-nCoV) outbreak

A. Vespignani, C. Viboud, S. Merler, 2020 .

Informing pandemic response in the face of uncertainty. An evaluation of the U.S. COVID-19 Scenario Modeling Hub

Thomas J. Hladish, Elizabeth C. Lee, A. Vespignani, 2023, medRxiv.

Cryptic transmission of SARS-CoV-2 and the first COVID-19 wave

A. Vespignani, C. Viboud, S. Merler, 2021, Nature.

Containing Pandemic Influenza at the Source : Supporting Online Material

A. Nizam, D. Cummings, M. Halloran, 2005 .

Estimating efficacy of trivalent, cold-adapted, influenza virus vaccine (CAIV-T) against influenza A (H1N1) and B using surveillance cultures.

H. Chu, M. Halloran, I. Longini, 2003, American journal of epidemiology.

Critical immune and vaccination thresholds for determining multiple influenza epidemic waves.

Ira M Longini, Laura Matrajt, I. Longini, 2012, Epidemics.

American Journal of Epidemiology Practice of Epidemiology Planning for the Control of Pandemic Influenza a (h1n1) in Los Angeles County and the United States

M. Halloran, I. Longini, N. Basta, 2022 .

Estimating the impact of COVID-19 vaccine allocation inequities: a modeling study

A. Vespignani, N. Perra, N. Dean, 2022, medRxiv.

Modeling Competing Infectious Pathogens From a Bayesian Perspective: Application to Influenza Studies With Incomplete Laboratory Results

D. Cummings, M. Daniels, I. Longini, 2010, Journal of the American Statistical Association.

Appendix Population level impact of an imperfect prophylactic HSV-2 vaccine

L. Abu-Raddad, J. Schiffer, I. Longini, 2009 .

Household transmissibility of avian influenza A (H7N9) virus, China, February to May 2013 and October 2013 to March 2014.

M. Halloran, I. Longini, E. Kenah, 2015, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Controlling Endemic Cholera with Oral Vaccines

A. Nizam, I. Longini, N. Shenvi, 2007, PLoS medicine.

El Tor cholera with severe disease: a new threat to Asia and beyond

A. Nizam, I. Longini, R. Colwell, 2009, Epidemiology and Infection.

Antiviral resistance and the control of pandemic influenza: the roles of stochasticity, evolution and model details.

I. Longini, A. Handel, R. Antia, 2009, Journal of theoretical biology.

R0 and Deterministic Models

M. Halloran, I. Longini, C. Struchiner, 2010 .

Models of the Interaction of Host Genotypes and Infectious Disease

I. Longini, 1985 .

Ebola: mobility data.

A. Vespignani, A. Vespignani, J. Hyman, 2014, Science.